European Union - English - EMA (European Medicines Agency)

les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - salbutamol sulfate 120.525ug (equvalent to 100µg salbutamol anhydrous) - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.525ug (equvalent to 100µg salbutamol anhydrous) excipient: cryofluorane dichlorodifluoromethane sorbitan trioleate trichlorofluoromethane

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - salbutamol sulfate 120.525ug equivalent to 100 µg salbutamol anydrous - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.525ug equivalent to 100 µg salbutamol anydrous excipient: cryofluorane dichlorodifluoromethane sorbitan trioleate trichlorofluoromethane

India - English - Central Drugs Standard Control Organization

sresan ph. - ambroxol hcl.,salbutamol - tab - 30,2;mg

India - English - Central Drugs Standard Control Organization

sresan ph. - syr - 100ml

India - English - Central Drugs Standard Control Organization

sresan ph. - ambroxol hcl.,salbutamol - st tab - 15,1;mg

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - salbutamol sulfate 100ug - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 100ug

Bangladesh - English - DGDA (Directorate General of Drug Administration)

jayson pharmaceuticals ltd. - salbutamol - syrup - 2 mg/5 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

jayson pharmaceuticals ltd. - salbutamol - tablet - 4 mg